Skip to content

MOSAIC IMMUNOENGINEERING, INC.: 10-Q filed 2018-01-16

What MOSAIC IMMUNOENGINEERING, INC. reported in its quarterly report filed 2018-01-16 (fiscal Q2 2018): 24 published measures, 64 facts as tagged in accession 0001683168-18-000138.

This filing

Form
10-Q (quarterly report)
Filed
2018-01-16
Fiscal period
fiscal Q2 2018
Accession
0001683168-18-000138 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MOSAIC IMMUNOENGINEERING, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-11-303,111,535USD
At 2017-05-313,761,051USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-11-3050,773USD
At 2017-05-3156,587USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-11-303,060,762USD
At 2017-05-313,704,464USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-11-30445,194USD
At 2017-05-31979,641USD
At 2016-11-302,096,694USD
At 2016-05-311,159,576USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-09-01 to 2017-11-30-351,036USD91
2017-06-01 to 2017-11-30-643,702USD183
2016-09-01 to 2016-11-30967,024USD91
2016-06-01 to 2016-11-30591,356USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-06-01 to 2017-11-30-484,447USD183
2016-06-01 to 2016-11-30-693,779USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-06-01 to 2017-11-300USD183
2016-06-01 to 2016-11-302,703USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-06-01 to 2017-11-30-50,000USD183
2016-06-01 to 2016-11-301,630,897USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-11-30-59,761,814USD
At 2017-05-31-59,118,112USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-09-01 to 2017-11-30398,548,318shares91
2017-06-01 to 2017-11-30398,548,318shares183
2016-09-01 to 2016-11-30398,548,318shares91
2016-06-01 to 2016-11-30398,548,318shares183

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-09-01 to 2017-11-30398,548,318shares91
2017-06-01 to 2017-11-30398,548,318shares183
2016-09-01 to 2016-11-30401,392,948shares91
2016-06-01 to 2016-11-30401,392,948shares183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-09-01 to 2017-11-300USD91
2017-06-01 to 2017-11-302,400USD183
2016-09-01 to 2016-11-300USD91
2016-06-01 to 2016-11-302,400USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-11-301,427USD
At 2017-05-311,877USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-11-302,786,012USD
At 2017-05-313,317,186USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-11-3050,773USD
At 2017-05-3156,587USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-11-309,227USD
At 2017-05-3113,786USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-09-01 to 2017-11-30254,159USD91
2017-06-01 to 2017-11-30537,483USD183
2016-09-01 to 2016-11-30284,244USD91
2016-06-01 to 2016-11-30606,616USD183

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-09-01 to 2017-11-30254,159USD91
2017-06-01 to 2017-11-30537,483USD183
2016-09-01 to 2016-11-30284,244USD91
2016-06-01 to 2016-11-30606,616USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-11-30401,392,948shares
At 2017-05-31401,392,948shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-11-3077,444,062USD
At 2017-05-3177,444,062USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-11-3041,546USD
At 2017-05-3142,801USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-06-01 to 2017-11-30450USD183
2016-06-01 to 2016-11-30375USD183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-09-01 to 2017-11-30-96,877USD91
2017-06-01 to 2017-11-30-103,819USD183
2016-09-01 to 2016-11-301,251,268USD91
2016-06-01 to 2016-11-301,200,372USD183

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-06-01 to 2017-11-302,400USD183
2016-06-01 to 2016-11-302,300USD183

Inspect the source

Entity
MOSAIC IMMUNOENGINEERING, INC. / CIK 0000836564
Captured
2026-09-19T15:08:56.564Z
SEC response SHA-256
20b7dbddee8b1aee5cb56cb4cf5c3c14c36ef1fafb538ec0211cfb2585ddf3fd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000836564.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))